Contact Person : Katelin Fitzgerald; Last Date for the submission of abstract : Not Available ; Description : This year's event has been expanded to five days with coverage on adjuvants, vaccine and immunotherapy technologies, immunomodulatory therapeutic antibodies for cancer, combination cancer immunotherapy, and T cell target discovery.